GE HealthCare’s $945 Million Sofie Biosciences Deal Expands Diagnostics M&A Push
GE HealthCare’s proposed $945 million Sofie Biosciences acquisition highlights its diagnostics and radiopharmaceutical strategy.
Cenovus-Athabasca $5.7 Billion Deal Tests Canadian Oil Sands M&A Appetite
Cenovus’s proposed $5.7 billion cash-and-stock acquisition of Athabasca puts Canadian oil sands consolidation back in fo…
Airlines Cut Capacity as Jet Fuel Costs Pressure Margins Despite Higher Fares
Airlines are trimming capacity as jet-fuel prices rise, but resilient demand and higher fares may not protect margins ah…
Fathom and Neighborhood Intelligence End Merger, Leaving Nasdaq Investors to Revalue Both Stocks
Fathom and Neighborhood Intelligence ended their proposed merger, removing deal value and forcing investors to reassess …
Informed positions start with informed mornings.
Market-moving analysis and institutional-grade research, complimentary and delivered daily.